Los Angeles Convention Center
Los Angeles, CA
May 16-20, 2023

Touchlight DNA Services  

United Kingdom

We look forward to meeting you at Booth 212 at ASGCT

DNA Manufacturing for advanced therapy production

Touchlight DNA Services provide rapid, enzymatic DNA development and manufacturing for all advanced therapy production, including mRNA, non-viral gene therapy, AAV, lentivirus, genome editing and DNA API.

Touchlight’s novel, synthetic DNA vector known as doggybone DNA (dbDNA™), is an antibiotic resistance free DNA vector with fast manufacturing timelines for research through to GMP applications.

dbDNA is a minimal, linear, covalently closed structure, that eliminates bacterial sequences. Touchlight’s revolutionary enzymatic production platform enables unprecedented speed, scale, and the ability to target genes with a size and complexity that is impossible with current technologies.

Clients can be supported from pre-clinical through development and supply, to licencing and tech transfer for use in-house.

How dbDNA can help you.

  • Reduced timelines
  • Improved quality, safety, and reliability
  • Avoidance of quality issues caused by complexity of sequence
  • Reduced costs at scale

Learn more about how doggybone DNA is made

Brands: doggybone DNA dbDNA